atenolol has been researched along with Necrosis in 11 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Necrosis: The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe the dermatological consequences of treatment with a beta-adrenergic antagonist, atenolol, in a patient with pheochromocytoma." | 3.67 | Sweat-gland necrosis after beta-adrenergic antagonist treatment in a patient with pheochromocytoma. ( Derom, E; Naeyaert, JM; Rubens, R; Santosa, S, 1987) |
| " Hepatic pharmacokinetic modelling was performed with a two-phase physiologically-based organ pharmacokinetic model with the vascular space and dispersion evaluated with the MID technique." | 1.38 | Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage. ( Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Weiss, M; Zhang, Q, 2012) |
| " Thus, melatonin and atenolol appear to have some adverse effects in CO intoxication on the myocardial cells." | 1.33 | Effect of melatonin and atenolol on carbon monoxide cardiotoxicity: an experimental study in rats. ( Celbiş, O; Mizrak, B; Olmez, E; Parlakpinar, H, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (63.64) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, P | 1 |
| Robertson, TA | 1 |
| Zhang, Q | 1 |
| Fletcher, LM | 1 |
| Crawford, DH | 1 |
| Weiss, M | 1 |
| Roberts, MS | 1 |
| Panda, S | 1 |
| Kar, A | 1 |
| Banerjee, T | 1 |
| Sharma, N | 1 |
| Mizrak, B | 1 |
| Celbiş, O | 1 |
| Parlakpinar, H | 1 |
| Olmez, E | 1 |
| Bhatt, LK | 1 |
| Nandakumar, K | 1 |
| Bodhankar, SL | 1 |
| Bansal, J | 1 |
| Piplani, P | 1 |
| Kogan, AKh | 1 |
| Kudrin, AN | 1 |
| Mashkovskiĭ, MD | 1 |
| Miez-Gombyn, A | 1 |
| Iuzhakov, SD | 1 |
| Gokal, R | 1 |
| Dornan, TL | 1 |
| Ledingham, JG | 1 |
| Rees, PJ | 1 |
| Cruickshank, JM | 2 |
| Neil-Dwyer, G | 2 |
| Hayes, Y | 2 |
| Degaute, JP | 2 |
| Kuurne, T | 2 |
| Kytta, J | 2 |
| Carruthers, ME | 2 |
| Patel, S | 2 |
| Vincent, JL | 1 |
| Almagro, P | 1 |
| Moré, J | 1 |
| Naeyaert, JM | 1 |
| Derom, E | 1 |
| Santosa, S | 1 |
| Rubens, R | 1 |
2 trials available for atenolol and Necrosis
| Article | Year |
|---|---|
Stress/catecholamine-induced cardiac necrosis. Reduction by beta 1-selective blockade.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atenolol; Child; Clinical Trials as Topic; Craniocere | 1988 |
Reduction of stress/catecholamine-induced cardiac necrosis by beta 1-selective blockade.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Child; Clinical Trials as Topic; Cra | 1987 |
9 other studies available for atenolol and Necrosis
| Article | Year |
|---|---|
Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.
Topics: Adrenergic Antagonists; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti | 2012 |
Combined effects of quercetin and atenolol in reducing isoproterenol-induced cardiotoxicity in rats: possible mediation through scavenging free radicals.
Topics: Administration, Oral; Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Atenolol; Cardioto | 2012 |
Effect of melatonin and atenolol on carbon monoxide cardiotoxicity: an experimental study in rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Carbon Monoxide Poisoning; Carboxyhemoglobin; Female | 2006 |
Beta-blocking activity of PP-34, a newly synthesized aryloxypropanolamine derivative, and its cardioprotective effect against ischaemia/reperfusion injury in laboratory animals.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atenolol; Benzylamines; Female; Guinea P | 2007 |
[Effect of the beta-adrenoblockader atenolol on the extent of myocardial necrosis in transient and permanent coronary occlusion].
Topics: Animals; Atenolol; Coronary Disease; Injections, Intravenous; Male; Myocardium; Necrosis; Rats; Time | 1984 |
Peripheral skin necrosis complicating beta-blockage.
Topics: Aged; Atenolol; Drug Eruptions; Female; Foot; Foot Dermatoses; Humans; Ischemia; Male; Middle Aged; | 1979 |
Peripheral skin necrosis complicating beta-blockade.
Topics: Atenolol; Foot Dermatoses; Humans; Male; Middle Aged; Necrosis; Propanolamines; Skin | 1979 |
[Atenolol-induced skin necrosis].
Topics: Atenolol; Humans; Male; Middle Aged; Necrosis; Skin Diseases | 1988 |
Sweat-gland necrosis after beta-adrenergic antagonist treatment in a patient with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Atenolol; Female; Humans; Necrosis; Pheochromocytoma; Sweat Gland Di | 1987 |